AI in Cardiology Market Revenue 2024 to 2034
AI in Cardiology Market Revenue 2024 to 2034
The global AI in cardiology market size is expected to increase from USD 2.56 billion in 2025 to USD 36.64 billion by 2034, growing at a CAGR of 34.38% throughout the forecast period from 2025 to 2034, as a result of the rising prevalence of cardiovascular disorders and improve technological advancements.
Report ID: 10087
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 1.91 Bn
Forecast Year,
USD USD 36.64 Bn
CAGR, 2025 -
34.38%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
AI in Cardiology Market Size Analysis
AI in Cardiology Market Size By Component 2024 to 2034 (USD )
| Component | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hardware | 477.50 | 647.42 | 877.70 | 1189.72 | 1612.47 | 2185.18 | 2960.93 | 4011.62 | 5434.52 | 7361.30 | 9970.12 |
| Software | 955.00 | 1271.81 | 1693.68 | 2255.42 | 3003.39 | 3999.28 | 5325.26 | 7090.64 | 9440.99 | 12570.01 | 16735.56 |
| Services | 477.50 | 647.42 | 877.70 | 1189.72 | 1612.47 | 2185.18 | 2960.93 | 4011.62 | 5434.52 | 7361.30 | 9970.12 |
AI in Cardiology Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosis | 668.50 | 906.03 | 1227.87 | 1663.92 | 2254.66 | 3054.92 | 4138.94 | 5607.25 | 7595.95 | 10289.31 | 13936.81 |
| Prediction | 477.50 | 633.96 | 841.57 | 1117.00 | 1482.34 | 1966.86 | 2609.33 | 3461.08 | 4590.07 | 6086.25 | 8068.68 |
| Drug Discovery | 382.00 | 521.03 | 710.51 | 968.69 | 1320.41 | 1799.47 | 2451.87 | 3340.17 | 4549.45 | 6195.42 | 8435.44 |
| Others | 382.00 | 505.63 | 669.12 | 885.26 | 1170.93 | 1548.38 | 2046.98 | 2705.38 | 3574.56 | 4721.62 | 6234.89 |
AI in Cardiology Market Size By Medical Condition 2024 to 2034 (USD )
| Medical Condition | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ischemic Heart Disease/CAD | 764.00 | 1034.36 | 1400.32 | 1895.66 | 2566.07 | 3473.40 | 4701.29 | 6362.94 | 8611.45 | 11653.95 | 15770.60 |
| Cardiac Arrhythmias | 477.50 | 633.96 | 841.57 | 1117.00 | 1482.34 | 1966.86 | 2609.33 | 3461.08 | 4590.07 | 6086.25 | 8068.68 |
| Heart Failure | 382.00 | 521.03 | 710.51 | 968.69 | 1320.41 | 1799.47 | 2451.87 | 3340.17 | 4549.45 | 6195.42 | 8435.44 |
| Others | 286.50 | 377.30 | 496.67 | 653.52 | 859.51 | 1129.90 | 1484.62 | 1949.69 | 2559.06 | 3356.99 | 4401.10 |
AI in Cardiology Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 668.50 | 903.32 | 1220.55 | 1649.08 | 2227.92 | 3009.77 | 4065.76 | 5491.92 | 7417.92 | 10018.81 | 13530.88 |
| Europe | 477.50 | 632.07 | 836.55 | 1107.04 | 1464.77 | 1937.80 | 2563.19 | 3389.89 | 4482.49 | 5926.24 | 7833.67 |
| Asia-Pacific | 477.50 | 647.42 | 877.70 | 1189.72 | 1612.47 | 2185.18 | 2960.93 | 4011.62 | 5434.52 | 7361.30 | 9970.12 |
| Latin America | 152.80 | 197.04 | 253.71 | 326.14 | 418.50 | 535.99 | 684.99 | 873.38 | 1110.70 | 1408.48 | 1780.38 |
| Middle East & Africa | 133.70 | 186.81 | 260.57 | 362.89 | 504.67 | 700.91 | 972.25 | 1347.07 | 1864.40 | 2577.78 | 3560.76 |
AI in Cardiology Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
